Yamamoto, Hirona
Lee-Okada, Hyeon-Cheol https://orcid.org/0000-0002-5493-8112
Ikeda, Masashi https://orcid.org/0000-0001-6237-2449
Nakamura, Takumi https://orcid.org/0000-0002-5611-6534
Saito, Takeo
Takata, Atsushi https://orcid.org/0000-0002-0928-4586
Yokomizo, Takehiko
Iwata, Nakao https://orcid.org/0000-0003-3189-6076
Kato, Tadafumi https://orcid.org/0000-0001-7856-3952
Kasahara, Takaoki https://orcid.org/0000-0002-0953-5146
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP20dm017097)
Japan Agency for Medical Research and Development (JP22wm0425008)
Japan Agency for Medical Research and Development (JP22wm0425008)
Japan Agency for Medical Research and Development (JP16dm0107098)
Japan Agency for Medical Research and Development (JP20dm017097)
Japan Agency for Medical Research and Development (JP22wm0425008)
Article History
Received: 25 March 2022
Revised: 26 January 2023
Accepted: 30 January 2023
First Online: 21 February 2023
Competing interests
: NI has received research support or speakers’ honoraria from Jansen, Takeda, Sumitomo Dainippon Pharma, and Otsuka. T Kat has received a research grant and personal fees from Sumitomo Dainippon Pharma outside of this work. The other authors declare that they have no conflict of interest.